Journal of Drugs in DermatologyHair Regrowth Following a Wnt- and Follistatin Containing Treatment: Safety and Efficacy in a First-in-Man Phase 1 Clinical Trial

Data from the pilot clinical trial of Histogen's Hair Stimulating Complex (HSC) for the
treatment of male pattern hair loss has been published in the November 2011 issue of
the peer-reviewed Journal of Drugs in Dermatology

View Abstract

Product Update
Hair Stimulating Complex (HSC) shows continued significant hair growth one year after treatment in first human clinical trial.

 Read more

Top 300 Startup by fundedIDEAS for 2011!
Histogen named a Top 300 Startup by fundedIDEAS for 2011! Company successfully completes Series A financing round, and opens Series B, with Phase I / II trial beginning this Spring.

 Read more

© Histogen Inc., CA 92121